CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+15.27%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$17.3B
AUM Growth
+$1.38B
(+8.6%)
Cap. Flow
-$439M
Cap. Flow
% of AUM
-2.53%
Top 10 Holdings %
Top 10 Hldgs %
32.07%
Holding
736
New
61
Increased
217
Reduced
342
Closed
55
Top Buys
| 1 |
Broadcom
AVGO
|
$108M |
| 2 |
Abbott
ABT
|
$55.5M |
| 3 |
Exelon
EXC
|
$45.5M |
| 4 |
Boston Scientific
BSX
|
$45.2M |
| 5 |
AbbVie
ABBV
|
$32.4M |
Top Sells
| 1 |
Tesla
TSLA
|
$84.8M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$58.7M |
| 3 |
CrowdStrike
CRWD
|
$53.7M |
| 4 |
Merck
MRK
|
$39.1M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$38.2M |
Sector Composition
| 1 | Technology | 36.26% |
| 2 | Healthcare | 22.75% |
| 3 | Financials | 10.33% |
| 4 | Consumer Discretionary | 7.75% |
| 5 | Industrials | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Airbnb
ABNB
$75.8B
| $3.4M | 0.02% |
25,662
-514
| -2% | -$68K |
|
402
Penumbra
PEN
$11B
| $3.37M | 0.02% |
+13,148
| New | +$3.37M |
|
403
Enel Chile
ENIC
$5.12B
| $3.37M | 0.02% |
928,000
+183,000
| +25% | +$664K |
|
404
Kenvue
KVUE
$35.7B
| $3.31M | 0.02% |
158,322
+23,270
| +17% | +$487K |
|
405
M&T Bank
MTB
$31.2B
| $3.3M | 0.02% |
16,997
-92,175
| -84% | -$17.9M |
|
406
Huntington Bancshares
HBAN
$25.7B
| $3.29M | 0.02% |
196,043
+15,723
| +9% | +$264K |
|
407
Gen Digital
GEN
$18.2B
| $3.28M | 0.02% |
111,716
-4,713
| -4% | -$139K |
|
408
Realty Income
O
$54.2B
| $3.28M | 0.02% |
56,898
-28,468
| -33% | -$1.64M |
|
409
Baker Hughes
BKR
$44.9B
| $3.24M | 0.02% |
84,377
-10,648
| -11% | -$408K |
|
410
EOG Resources
EOG
$64.4B
| $3.22M | 0.02% |
26,934
-8,096
| -23% | -$968K |
|
411
Expeditors International
EXPD
$16.4B
| $3.18M | 0.02% |
27,802
+767
| +3% | +$87.6K |
|
412
Graphic Packaging
GPK
$6.38B
| $3.17M | 0.02% |
150,536
-17,300
| -10% | -$365K |
|
413
Ares Management
ARES
$38.9B
| $3.14M | 0.02% |
+18,114
| New | +$3.14M |
|
414
Darling Ingredients
DAR
$5.07B
| $3.12M | 0.02% |
82,306
-1,997
| -2% | -$75.8K |
|
415
Hubbell
HUBB
$23.2B
| $3.12M | 0.02% |
7,643
+1,163
| +18% | +$475K |
|
416
MSCI
MSCI
$42.9B
| $3.08M | 0.02% |
5,346
-766
| -13% | -$442K |
|
417
Cogent Biosciences
COGT
$1.82B
| $3.07M | 0.02% |
+427,342
| New | +$3.07M |
|
418
PACCAR
PCAR
$52B
| $3.04M | 0.02% |
31,988
-6,176
| -16% | -$587K |
|
419
Nurix Therapeutics
NRIX
$758M
| $2.99M | 0.02% |
262,384
-326,547
| -55% | -$3.72M |
|
420
T Rowe Price
TROW
$23.8B
| $2.98M | 0.02% |
30,931
+5,236
| +20% | +$505K |
|
421
Immunome
IMNM
$916M
| $2.96M | 0.02% |
+318,086
| New | +$2.96M |
|
422
Edison International
EIX
$21B
| $2.95M | 0.02% |
57,085
+866
| +2% | +$44.7K |
|
423
Edgewise Therapeutics
EWTX
$1.64B
| $2.94M | 0.02% |
223,990
-1,806
| -0.8% | -$23.7K |
|
424
Phillips 66
PSX
$53.2B
| $2.93M | 0.02% |
24,522
-1,750
| -7% | -$209K |
|
425
PG&E
PCG
$33.2B
| $2.92M | 0.02% |
209,684
+10,543
| +5% | +$147K |
|